Marla Karine Amarante

1.1k total citations
54 papers, 892 citations indexed

About

Marla Karine Amarante is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Marla Karine Amarante has authored 54 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Oncology and 16 papers in Immunology. Recurrent topics in Marla Karine Amarante's work include Chemokine receptors and signaling (10 papers), Immunotherapy and Immune Responses (8 papers) and Acute Lymphoblastic Leukemia research (7 papers). Marla Karine Amarante is often cited by papers focused on Chemokine receptors and signaling (10 papers), Immunotherapy and Immune Responses (8 papers) and Acute Lymphoblastic Leukemia research (7 papers). Marla Karine Amarante collaborates with scholars based in Brazil, United States and Netherlands. Marla Karine Amarante's co-authors include Maria Angélica Ehara Watanabe, José Maurício Sforcin, Bruno José Conti, Julie Massayo Maeda Oda, Carlos Eduardo Coral de Oliveira, Roberta Losi Guembarovski, Júlio César Voltarelli, Glauco Akelinghton Freire Vitiello, Karen Brajão de Oliveira and Maria Helena Pelegrinelli Fungaro and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cellular and Molecular Life Sciences and International Journal of Environmental Research and Public Health.

In The Last Decade

Marla Karine Amarante

50 papers receiving 871 citations

Peers

Countries citing papers authored by Marla Karine Amarante

Since Specialization

Citations

This map shows the geographic impact of Marla Karine Amarante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marla Karine Amarante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marla Karine Amarante more than expected).

Fields of papers citing papers by Marla Karine Amarante

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marla Karine Amarante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marla Karine Amarante. The network helps show where Marla Karine Amarante may publish in the future.

Co-authorship network of co-authors of Marla Karine Amarante

This figure shows the co-authorship network connecting the top 25 collaborators of Marla Karine Amarante. A scholar is included among the top collaborators of Marla Karine Amarante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marla Karine Amarante. Marla Karine Amarante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genome-wide gene expression changes in breast cancer cells following very low-dose exposure to pesticides (glyphosate and atrazine) at drinking water levels 2025 ·Environmental Toxicology and Pharmacology ·Carolina Panis, (unknown), Scott M. Smith, José Antonio Mateo, Marla Karine Amarante, (unknown), Wander Rogério Pavanelli, (unknown), Renata Santos Rabelo, (unknown), (unknown), Bernardo Lemos	0
2	Evidence concerning parental exposure to pesticides and the occurrence of leukemia in offspring: a systematic review 2025 ·Frontiers in Pediatrics ·(unknown), (unknown), Marla Karine Amarante, Carolina Panis	0
3	Dermatological Manifestations in COVID-19: A Case Study of SARS-CoV-2 Infection in a Genetic Thrombophilic Patient with Mthfr Mutation 2023 ·Pathogens ·(unknown), Marla Karine Amarante, Eliana Carolina Vespero, Eliandro Reis Tavares, Lucy Megumi Yamauchi, (unknown), Danielle Bruna Leal Oliveira, Edison Luíz Durigon, Sueli Fumie Yamada‐Ogatta, Lígia Carla Faccin‐Galhardi	1
4	Involvement of APOBEC3A/B Deletion in Mouse Mammary Tumor Virus (MMTV)-like Positive Human Breast Cancer 2023 ·Diagnostics ·(unknown), Glauco Akelinghton Freire Vitiello, Marla Karine Amarante	2
5	Involvement of CXCL12/CXCR4 axis in colorectal cancer: a mini-review 2023 ·Molecular Biology Reports ·(unknown), (unknown), Karen Brajão de Oliveira, Marla Karine Amarante	10
6	Expression of Ki67 and p53 Proteins: Breast Cancer Aggressivity Markers in Brazilian Young Patients 2020 ·Journal of Adolescent and Young Adult Oncology ·(unknown), (unknown), Rejane Kiyomi Furuya, (unknown), Roberta Losi Guembarovski, Glauco Akelinghton Freire Vitiello, Marla Karine Amarante, Maria Angélica Ehara Watanabe	4
7	Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort 2020 ·Journal of Cancer Research and Clinical Oncology ·Glauco Akelinghton Freire Vitiello, (unknown), Marla Karine Amarante, Bruna Karina Banin Hirata, (unknown), Karen Brajão de Oliveira, Roberta Losi Guembarovski, Maria Angélica Ehara Watanabe	5
8	Transforming growth factor beta 1 (TGFβ1) plasmatic levels in breast cancer and neoplasia-free women: Association with patients’ characteristics and TGFB1 haplotypes 2020 ·Cytokine ·Glauco Akelinghton Freire Vitiello, Marla Karine Amarante, Julie Massayo Maeda Oda, Bruna Karina Banin Hirata, Carlos Eduardo Coral de Oliveira, (unknown), Karen Brajão de Oliveira, Roberta Losi Guembarovski, Maria Angélica Ehara Watanabe	6
9	Involvement of a mouse mammary tumor virus (MMTV) homologue in human breast cancer: Evidence for, against and possible causes of controversies 2019 ·Microbial Pathogenesis ·Marla Karine Amarante, (unknown), Glauco Akelinghton Freire Vitiello, Maria Angélica Ehara Watanabe	27
10	Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes 2019 ·Breast Cancer Research and Treatment ·Glauco Akelinghton Freire Vitiello, Marla Karine Amarante, Bruna Karina Banin Hirata, (unknown), Karen Brajão de Oliveira, Roberta Losi Guembarovski, Maria Angélica Ehara Watanabe	9
11	An overview of the immune response and Arginase I on CHIKV immunopathogenesis 2019 ·Microbial Pathogenesis ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Marla Karine Amarante, Maria Angélica Ehara Watanabe	2
12	Transforming growth factor beta 1 (TGFβ1) polymorphisms and haplotype structures have dual roles in breast cancer pathogenesis 2018 ·Journal of Cancer Research and Clinical Oncology ·Glauco Akelinghton Freire Vitiello, Roberta Losi Guembarovski, Bruna Karina Banin Hirata, Marla Karine Amarante, Carlos Eduardo Coral de Oliveira, Karen Brajão de Oliveira, Guilherme Cesar Martelossi Cebinelli, (unknown), (unknown), Maria Angélica Ehara Watanabe	20
13	CXCL12/CXCR4 axis in the pathogenesis of acute lymphoblastic leukemia (ALL): a possible therapeutic target 2015 ·Cellular and Molecular Life Sciences ·(unknown), Marla Karine Amarante, Roberta Losi Guembarovski, Carlos Eduardo Coral de Oliveira, Maria Angélica Ehara Watanabe	38
14	CXCL12 and TP53 genetic polymorphisms as markers of susceptibility in a Brazilian children population with acute lymphoblastic leukemia (ALL) 2013 ·Molecular Biology Reports ·(unknown), Roberta Losi Guembarovski, Julie Massayo Maeda Oda, (unknown), Carolina Batista Ariza, Marla Karine Amarante, Maria Helena Pelegrinelli Fungaro, Karen Brajão de Oliveira, Maria Angélica Ehara Watanabe	20
15	Caveolin Involvement and Modulation in Breast Cancer 2011 ·Mini-Reviews in Medicinal Chemistry ·Mateus Nóbrega Aoki, Marla Karine Amarante, Julie Massayo Maeda Oda, Maria Angélica Ehara Watanabe	11
16	Regulatory T cells and breast cancer: implications for immunopathogenesis 2010 ·Cancer and Metastasis Reviews ·Maria Angélica Ehara Watanabe, Julie Massayo Maeda Oda, Marla Karine Amarante, Júlio César Voltarelli	104
17	Toll-Like Receptor 3: Involvement with Exogenous and Endogenous RNA 2010 ·International Reviews of Immunology ·Marla Karine Amarante, Maria Angélica Ehara Watanabe	23
18	Plasma malondialdehyde levels and CXCR4 expression in peripheral blood cells of breast cancer patients 2009 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Suzana Lucy Nixdorf, Mário Sérgio Mantovani, Ana Cristina da Silva do Amaral Herrera, Mateus Nóbrega Aoki, Marla Karine Amarante, Bruno Fabris, Maria Helena Pelegrinelli Fungaro, Maria Angélica Ehara Watanabe	29
19	The possible involvement of virus in breast cancer 2008 ·Journal of Cancer Research and Clinical Oncology ·Marla Karine Amarante, Maria Angélica Ehara Watanabe	90
20	RNA from Borna disease virus in patients with schizophrenia, schizoaffective patients, and in their biological relatives 2008 ·Journal of Clinical Laboratory Analysis ·(unknown), Eiko Nakagawa Itano, Marla Karine Amarante, Edna Maria Vissoci Reiche, Helen C. Miranda, Carlos Eduardo Coral de Oliveira, Tiemi Matsuo, (unknown), Maria Angélica Ehara Watanabe	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact